Publications by authors named "JeanPierre Evenou"

Claim this Profile
I
Indolyl-naphthyl-maleimides as potent and selective inhibitors of protein kinase C-α/β.
Maurice J van Eis, JeanPierre Evenou, Walter Schuler, Gerhard Zenke, Eric Vangrevelinghe

Bioorg Med Chem Lett· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,6-Naphthyridines as potent and selective inhibitors of the novel protein kinase C isozymes.
Maurice J van Eis, Jean-Pierre Evenou, Philipp Floersheim, Christoph Gaul, Sandra W Cowan-Jacob

Bioorg Med Chem Lett· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis.
Jürgen Wagner, Peter von Matt, Bernard Faller, Nigel G Cooke, Rainer Albert, Jean-Pierre Evenou

J Med Chem· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes.
Jürgen Wagner, Peter von Matt, Richard Sedrani, Rainer Albert, Nigel Cooke, Jean-Pierre Evenou

J Med Chem· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation.
Jean-Pierre Evenou, Jürgen Wagner, Gerhard Zenke, Volker Brinkmann, Kathrin Wagner

J Pharmacol Exp Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis